Overview Financials News + Filings
All
All (ex-4s)
10-K
10-Q
8-K
3,4,5
Proxy
Prospectus
Other
Tags
Appointed director
|
|
Arrestage International, Inc.
|
Create: Alert |
All | News | Filings
| Date Filed | Type | Description |
| 11/04/2019 |
8-K
| Departure of Directors or Certain Officers; Election of Directors; Appointment of Certain Officers: Compensatory Arrangements... |
| 09/19/2019 |
8-K
| Departure of Directors or Certain Officers; Election of Directors; Appointment of Certain Officers: Compensatory Arrangements... |
| 09/19/2019 |
8-K
| Departure of Directors or Certain Officers; Election of Directors; Appointment of Certain Officers: Compensatory Arrangements... |
| 09/19/2019 |
8-K
| Appointed a new director |
| 07/29/2019 |
8-K
| Quarterly results |
| 10/17/2018 |
8-K
| Regulation FD Disclosure, Financial Statements and Exhibits|
Docs:
|
"Arrestage International, Inc. Announces Effectiveness of its S-1 Registration Statement Scottsdale, Arizona, October 17, 2018 – Arrestage International, Inc. , an innovative company that that plans to offer proprietary pain relief, skin care, anti-aging products and branding concepts, as well as medical device rentals to the nutraceutical and medical industries respectively, announced today that its Form S-1 Registration Statement as filed with the U.S. Securities and Exchange Commission has been accepted and is effective as of October 11, 2018. Following the effective date, the Company will be subject to the reporting requirements of the Exchange Act of 1934, as amended. This means the Company will be begin filing annual reports with the SEC on Form 10-K, quarterly reports on Form 10-Q, p..." |
|
|
|